FDA deems new drug “breakthrough” for breast cancer
Mercy’s nurse genetic counselor Sharon Nall joined us in studio to talk about what women can do.
Researchers at UCLA are studying an experimental new drug for breast cancer and the results have been dramatic.
The drug may be able to stop the spread of cancer cells without the side effects associated with chemotherapy.
The new compound is called Palbociclib and it targets a protein, CDK46, which causes the cancer cells to spread.
In initial tests, Palbociclib helped to stop cancer growth in its tracks.
The FDA was so impressed with the results that is designated Palbociclib a breakthrough drug which speeds up the approval process so it can be available to the public.
The clinical trials are still enrolling study participants.